Skip to main content
. Author manuscript; available in PMC: 2011 May 20.
Published in final edited form as: Neuropsychopharmacology. 2007 May 9;33(3):465–472. doi: 10.1038/sj.npp.1301444

Table 1.

Baseline Demographic and Clinical Characteristics of the Study Sample

Placebo (n=54) CX516 (n=51)
Gender (M/F) 43/11 44/7
Race (W/B/A/O) 37/8/7/2 39/9/6/0
Age (years) 43.7±11.0 42.0±9.3
Education (years) 11.9±2.6 11.6±2.4
NAART 35.0±12.6 36.4±13.7
Antipsychotic (n) Mean dose
Clozapine (27) 426±214 (24) 432±147
Olanzapine (18) 19.3±7.1 (18) 22.4±9.3
Risperidone (9) 4.1±2.3 (9) 4.0±1.1